114 related articles for article (PubMed ID: 10411797)
1. Reduced thermoregulatory null zone in postmenopausal women with hot flashes.
Freedman RR; Krell W
Am J Obstet Gynecol; 1999 Jul; 181(1):66-70. PubMed ID: 10411797
[TBL] [Abstract][Full Text] [Related]
2. Disabling symptoms associated with increased axillary temperature in patients with functional hyperthermia.
Oka T
Biopsychosoc Med; 2024 Mar; 18(1):9. PubMed ID: 38528522
[TBL] [Abstract][Full Text] [Related]
3. Physiology of hot flashes.
Freedman RR
Am J Hum Biol; 2001; 13(4):453-64. PubMed ID: 11400216
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and treatment of menopausal hot flashes.
Freedman RR
Semin Reprod Med; 2005 May; 23(2):117-25. PubMed ID: 15852197
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of exercise for menopausal symptoms: a randomized controlled trial.
Sternfeld B; Guthrie KA; Ensrud KE; LaCroix AZ; Larson JC; Dunn AL; Anderson GL; Seguin RA; Carpenter JS; Newton KM; Reed SD; Freeman EW; Cohen LS; Joffe H; Roberts M; Caan BJ
Menopause; 2014 Apr; 21(4):330-8. PubMed ID: 23899828
[TBL] [Abstract][Full Text] [Related]
6. Hot flashes: behavioral treatments, mechanisms, and relation to sleep.
Freedman RR
Am J Med; 2005 Dec; 118 Suppl 12B():124-30. PubMed ID: 16414337
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism.
Casper RF; Yen SS
Clin Endocrinol (Oxf); 1985 Mar; 22(3):293-312. PubMed ID: 3884189
[No Abstract] [Full Text] [Related]
8. Core body temperature and circadian rhythm of hot flashes in menopausal women.
Freedman RR; Norton D; Woodward S; Cornélissen G
J Clin Endocrinol Metab; 1995 Aug; 80(8):2354-8. PubMed ID: 7629229
[TBL] [Abstract][Full Text] [Related]
9. Menopausal flushes: a neuroendocrine link with pulsatile luteninizing hormone secreation.
Casper RF; Yen SS; Wilkes MM
Science; 1979 Aug; 205(4408):823-5. PubMed ID: 462193
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hot flashes: mechanisms, endocrinology, treatment.
Freedman RR
J Steroid Biochem Mol Biol; 2014 Jul; 142():115-20. PubMed ID: 24012626
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.
Gold EB; Colvin A; Avis N; Bromberger J; Greendale GA; Powell L; Sternfeld B; Matthews K
Am J Public Health; 2006 Jul; 96(7):1226-35. PubMed ID: 16735636
[TBL] [Abstract][Full Text] [Related]
12. Duration of menopausal vasomotor symptoms over the menopause transition.
Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
[TBL] [Abstract][Full Text] [Related]
14. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes.
Rance NE; Dacks PA; Mittelman-Smith MA; Romanovsky AA; Krajewski-Hall SJ
Front Neuroendocrinol; 2013 Aug; 34(3):211-27. PubMed ID: 23872331
[TBL] [Abstract][Full Text] [Related]
15. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
Deecher DC; Dorries K
Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the relationship between temperature and immunity.
Maloney E; Duffy D
Discov Immunol; 2024; 3(1):kyae001. PubMed ID: 38567294
[TBL] [Abstract][Full Text] [Related]
17. The influence of habitual physical activity and sedentary behavior on objective and subjective hot flashes at midlife.
Witkowski S; White Q; Shreyer S; Brown DE; Sievert LL
Menopause; 2024 May; 31(5):381-389. PubMed ID: 38530999
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis.
Rhodes JR; Alldredge CT; Elkins GR
Front Psychiatry; 2023; 14():1204163. PubMed ID: 37599891
[TBL] [Abstract][Full Text] [Related]
19. Vasomotor symptoms of menopause, autonomic dysfunction, and cardiovascular disease.
Lee E; Anselmo M; Tahsin CT; Vanden Noven M; Stokes W; Carter JR; Keller-Ross ML
Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1270-H1280. PubMed ID: 36367692
[TBL] [Abstract][Full Text] [Related]
20. Resistance training reduced luteinising hormone levels in postmenopausal women in a substudy of a randomised controlled clinical trial: A clue to how resistance training reduced vasomotor symptoms.
Nilsson S; Henriksson M; Berin E; Engblom D; Holm AS; Hammar M
PLoS One; 2022; 17(5):e0267613. PubMed ID: 35617333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
